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Résumé en
anglais
Cystic echinococcosis (CE), which is caused during the metacestode larval stage of
Echinococcus granulosus, is a life-threatening disease and is very difficult to treat. At
present, the FDA-approved antihelmintic drugs are mebendazole (MBZ), albendazole
(ABZ) and its principal metabolite ABZ sulfoxide (ABZSO), but as these have a
therapeutic efficacy over 50%, underlining the need for new drug delivery systems.
The aim of this work was the optimization and characterization of previously developed
ABZ lipid nanocapsules (ABZ-LNCs) and evaluate their efficacy in mice infected with E.
granulosus. LNCs were prepared by the phase inversion technique and characterized
in terms of size, surface charge, drug loading, and in vitro stability followed by an in
vivo proof-of-concept using a murine model infected with E. granulosus. Stable particle
dispersions with a narrow size distribution and high efficiency of encapsulation (≥90%)
were obtained. ABZ-LNCs showed a greater chemoprophylactic efficacy than ABZ
suspension administered by the oral route as 4 out of the 10 ABZ-LNCs treated mice
did not develop any cysts, whereas the infection progressed in all mice from the ABZ
suspension group. Regarding the ultrastructural studies of cysts, mice treated with
ABZ-LNCs or ABZ suspension revealed changes in the germinal layer. However, the
extent of the damage appeared to be greater after ABZ-LNC administration compared
to the suspension treatment. These results suggest that ABZ-LNCs could be a
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